Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019025512) TABLET COMPRISING EZETIMIBE
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2019/025512 International Application No.: PCT/EP2018/070920
Publication Date: 07.02.2019 International Filing Date: 01.08.2018
IPC:
A61K 9/20 (2006.01) ,A61K 31/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
20
Pills, lozenges or tablets
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
Applicants:
ADAMED PHARMA S.A. [PL/PL]; Mariana Adamkiewicza 6A, Pienkow 05-152 Czosnow, PL
Inventors:
WOZNIAK, Lukasz; PL
Agent:
SULIKOWSKI, Daniel; PL
Priority Data:
17461579.902.08.2017EP
Title (EN) TABLET COMPRISING EZETIMIBE
(FR) COMPRIMÉ COMPRENANT DE L'ÉZÉTIMIBE
Abstract:
(EN) The invention relates to a tablet comprising 5 to 20 %wt. ezetimibe, 5 to 20 %wt. plastic excipient, 3 to 10 %wt. disintegrant, 1 to 12 %wt. starch, 0.5 to 1.5 %wt. silica, 0.5 to 2.5 %wt. stearic acid, wherein a weight ratio stearic acid to silica is 1:1 to 3:1, and wherein the tablet comprises a further diluent and binder, and optionally surfactant.
(FR) La présente invention concerne un comprimé comprenant 5 à 20 % en masse d’ézétimibe, 5 à 20 % en masse d’un excipient plastique, 3 à 10 % en masse d’un agent délitant, 1 à 12 % en masse d’amidon, 0,5 à 1,5 % en masse de silice, 0,5 à 2,5 % en masse d'acide stéarique, dans lequel un rapport massique de l’acide stéarique sur la silice est compris entre 1 : 1 et 3 : 1, et dans lequel le comprimé comprend un diluant et agent liant supplémentaire, et éventuellement un tensioactif.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)